Yung H Chyung's most recent trade in Keros Therapeutics Inc was a trade of 44,000 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Yung H. Chyung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 44,000 | 44,000 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Yung H. Chyung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 110,000 | 110,000 | - | - | Employee Stock Option (right to buy) | |
| Scholar Rock Holding Corp | Yung H. Chyung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Yung H. Chyung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 37,500 | 258,496 (0%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Yung H. Chyung | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share. | 15 Jan 2022 | 1,421 | 220,996 (0%) | 0% | 19.5 | 27,657 | Common Stock |
| Scholar Rock Holding Corp | Yung H. Chyung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 52,500 | 225,534 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Yung H. Chyung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 15,750 | 15,750 (0%) | 0% | 0 | Common Stock |